Physician profile
Howard E Murphy
NPI 1063463842
$3,409.02
in general payments reported to CMS, 2019-2025
16 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $345 · 2021: $448 · 2022: $747 · 2023: $498 · 2024: $444 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,301.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $864.86 | 2022-2025 | Infuse, Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $808.54 | 2019-2023 | Cequa |
| Alcon Vision LLC | $680.32 | 2019-2025 | Total30, Precision7, Eysuvis |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $316.94 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $166.12 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $124.23 | 2021 | |
| Coopervision INC. | $100.49 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Abbvie INC. | $91.72 | 2022 | |
| Allergan, INC. | $43.04 | 2020-2022 | |
| Biotissue Holdings INC. | $40.15 | 2021-2024 | |
| Kala Pharmaceuticals, INC. | $37.12 | 2021 | |
| Oyster Point Pharma, INC. | $36.45 | 2023 | Tyrvaya |
| Quidel Corporation | $36.23 | 2023 | |
| Dompe US, INC. | $26.54 | 2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $19.77 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.